Bunnage Mark E.
SEC CIK 2100735 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals | EVP, CSO | 7,284 | — | $3.00M | 9 | 2026-02-10 | 2026-05-15 |
Most active insiders at VRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| 2 | Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| 3 | Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| 4 | Bozic Carmen | EVP, CMO | — | $11.31M |
| 5 | WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| 6 | Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| 7 | McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| 8 | Biller Jonathan | EVP, CLO | — | $4.08M |
| 9 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| 10 | Bunnage Mark E. | EVP, CSO | — | $3.00M |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-19 16:05 | 2026-05-15 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | S - Sale | $453.45 | -33 | 7,284 | -0.5% | -$15.0K |
| 2026-02-26 | 2026-02-24 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | F - Tax | $485.11 | -582 | 7,904 | -7% | -$282.3K | |
| 2026-02-26 | 2026-02-25 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | S - Sale | $486.35 | -620 | 7,284 | -8% | -$301.5K | |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | S - Sale | $484.31 | -3,619 | 9,668 | -27% | -$1.75M |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | F - Tax | $483.75 | -1,110 | 12.1K | -8% | -$537.0K | |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | A - Grant | $0.00 | +2,584 | 13.2K | +24% | $0 | |
| 2026-02-18 | 2026-02-13 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | F - Tax | $487.76 | -2,283 | 10.6K | -18% | -$1.11M | |
| 2026-02-12 | 2026-02-11 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | S - Sale | $460.43 | -2,021 | 12.9K | -14% | -$930.5K | |
| 2026-02-12 | 2026-02-10 | VRTX | Vertex Pharmaceuticals | Bunnage Mark E. | EVP, CSO | F - Tax | $468.41 | -1,127 | 14.9K | -7% | -$527.9K |
Purchase Sale Sale after option exercise All abbreviations